Skip to Content
Current OncologyCurrent Oncology
  • Article
  • Open Access

9 September 2026

24 Pages

Assessing Quality Gaps and Clinician Perspectives on AI Integration in Colorectal Cancer NGS Pathways

,
,
,
,
,
,
,
,
…
1
School of Medicine, Queen’s University, Kingston, ON K7L 3N6, Canada
2
Department of Pathology and Molecular Medicine, Queen’s University, Kingston, ON K7L 3N6, Canada
3
Department of Biomedical and Molecular Sciences, Queen’s University, Kingston, ON K7L 3N6, Canada
4
Department of Laboratory Medicine & Pathobiology, Mount Sinai Hospital, Toronto, ON M5G 1X5, Canada
This article belongs to the Section Gastrointestinal Oncology

Simple Summary

For people with advanced colorectal cancer, choosing the most effective treatment depends on timely genetic testing of the tumour. When these results are delayed or hard to access, treatment may be postponed or started before the best targeted option is known. Because this testing involves many steps, from biopsy and pathology review through laboratory processing, reporting, and decision-making, delays and inefficiencies can arise. We interviewed 22 medical oncologists and pathologists from 14 hospitals across Ontario, Canada, to find where delays, omissions, and gaps occur, and to gauge their perspectives on wider use of digital tools and artificial intelligence in testing. Participants described vulnerabilities in how testing is started, tracked, owned, reported, and linked to electronic health records. They were optimistic that validated, clinician-supervised digital and artificial intelligence tools could help identify cases, track progress, and flag overdue results. These findings highlight practical ways to make testing more reliable and equitable.

Abstract

Next-generation sequencing (NGS) is integral to colorectal cancer (CRC) care, but its value depends on results being available when treatment decisions are made. We conducted a qualitative study to identify quality gaps in CRC NGS pathways and assess perspectives on digital and artificial intelligence (AI)-enabled workflow support. Semi-structured interviews were conducted with 22 medical oncologists and pathologists from 14 Ontario hospitals, and transcripts were analyzed thematically. Five themes emerged: (1) clinical indications and test ordering, where initiation was inconsistent because of unclear reflex-testing criteria, reliance on upstream clinicians, staging uncertainty, evolving indications, and funding constraints; (2) tissue, pathology, and laboratory workflow, where participants attributed bottlenecks and turnaround variability to send-out testing, staffing, infrastructure, and capacity; (3) interdisciplinary communication and tracking, where informal communication, unclear ownership, and manual tracking highlighted the need for closed-loop confirmation and alerts; (4) reporting and clinical integration, where report clarity, interpretability, and timing affected use; and (5) electronic health record integration and AI integration, where fragmented systems and limited interoperability delayed result access. Participants supported clinician-supervised digital or AI-enabled tools for case identification, triage, tracking, and overdue-result alerts. CRC NGS optimization requires standardized reflex criteria, clearer ownership, closed-loop tracking, reliable routing, structured reporting, and interoperable infrastructure.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.